Moreover, they suggest that the upregulation of APE1 protein expression levels observed in hepatic cancer cells may reflect an adaptive response to cell damage and may be responsible for further cell resistance to chemotherapy, as shown in other cancer cell models [49], [50]. The gene discussed is APEX1; the disease is liver cancer.